Looking for new biomarkers in bronchiectasis (BE): sputum Alpha1 antitrypsine (AAT), Neutrophil Elastase activity (NE) and secretory leucocyte protease inhibitor (SLPI). - Vienna 2024

Bronchiectasis across the life course

Chair(s): Amelia Shoemark, Gimano Amatngalim

Session type: Poster session

Looking for new biomarkers in bronchiectasis (BE): sputum Alpha1 antitrypsine (AAT), Neutrophil Elastase activity (NE) and secretory leucocyte protease inhibitor (SLPI).

Letizia Traversi

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Role of Tumour necrosis factor alpha in assessment of severity of Bronchiectasis

Santhiya Ramachandran

Poster

Abstract

Effectiveness of airway clearance techniques in non-cystic fibrosis bronchiectasis management in a real world setting

Michela Salvemini

Poster

Abstract

Long-term lung function and Pseudomonas aeruginosa in genotyped primary ciliary dyskinesia

Mathias G. Holgersen

Abstract

Looking for new biomarkers in bronchiectasis (BE): sputum Alpha1 antitrypsine (AAT), Neutrophil Elastase activity (NE) and secretory leucocyte protease inhibitor (SLPI).

Letizia Traversi

Poster

Abstract

Evaluation of Bronchiectasis in Children

Handan Keke

Poster

Abstract

Key components of an exacerbation recovery programme for people with bronchiectasis: patient and staff opinions and preferences

Jennifer Kilduff

Abstract

Questionnaire Survey on Use of Home Nebulized Antibiotics in Patients with Bronchiectasis (QUONAB)

Raja Dhar

Poster

Abstract

Gender-related diagnostic delay in bronchiectasis

Mariangela Valentina Puci

Poster

Abstract

Exhaled breath analysis in cystic fibrosis to detect Staphylococcus Aureus in the lungs.

David Mager

Poster

Abstract

Percentage Ciliation in Bronchiectasis Patient Upper and Lower Airways

Erin Cant

Poster

Abstract

Predictors of a delayed heart rate recovery after the 6-min walk test in people with bronchiectasis

Beatriz Herrero Cortina

Poster

Abstract

Infection with P. aeruginosa and H. influenzae in relation to QoL and symptoms in bronchiectasis patients requiring intravenous antibiotics; data from a European Bronchiectasis Registry (EMBARC) center.

Pia Ghosh

Poster

Abstract

Intermittent Positive Pressure Breathing devices reduce exacerbations in non-cystic fibrosis bronchiectasis patients

C?line Galor

Poster

Abstract

RhDNase improves quality of life and reduces exacerbations in primary ciliary dyskinesia

Moshe Heching

Poster

Abstract

Factors associated with frequent exacerbator's phenotype in non-cystic fibrosis bronchiectasis: a retrospective single centre analysis

Vittorio Chino

Poster

Abstract

Risk Stratification in Paediatric Primary Ciliary Dyskinesia (PCD)

Anne Armitage

Poster

Abstract

Temperature modifies ciliary beating in healthy subjects, but also in PCD and non-PCD patients

Noemie Bricmont

Poster

Abstract

Variability of lung function tests in primary ciliary dyskinesia

Felix Ratjen

Poster

Abstract

Clinical utility of rapid molecular diagnostics in acute exacerbation of bronchiectasis requiring hospitalisation: a prospective study

Charles Wong

Poster

Abstract

Non-cystic fibrosis bronchiectasis (NCFB) in Croatia: data from the European multicenter bronchiectasis audit and research collaboration (EMBARC) registry

Lorna Radman

Poster

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}